checkAd

     171  0 Kommentare Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference - Seite 3

    Forward-looking statements and information are based on the beliefs, assumptions, opinions, plans and expectations of Helix’s management on the date of this news release, and the Company does not assume any obligation to update any forward-looking statement or information should those beliefs, assumptions, opinions, plans or expectations, or other circumstances change, except as required by law.

    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    Helix BioPharma Corp. to Present at the Noble Capital Markets’ Sixteenth Annual Investor Conference - Seite 3 RICHMOND HILL, Ontario, Feb. 14, 2020 (GLOBE NEWSWIRE) - Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced …